Merck & Co. Inc. (MRK)

Index:

$ 110.97

By Michele Maatouk

Date: Friday 14 Nov 2025

(Sharecast News) - Shares in Cidara Therapeutics rocketed on Friday after the biotechnology firm agreed to be taken over by Merck in $9.2bn deal.

Merck to buy UK biotech Verona Pharma for $10bn	09-Jul-2025	ShareCast
US close: Stocks manage small gains on Ukraine-R...	26-Mar-2025	ShareCast
Merck shares fall on weak outlook, Gardasil Chin...	04-Feb-2025	ShareCast
Merck in global license agreement with Hansoh Ph...	18-Dec-2024	ShareCast
Merck tops Q3 earnings forecasts despite slower ...	31-Oct-2024	ShareCast

Merck increases antibiotic offering with $9.5bn ...	09-Dec-2014	Telegraph
Reckitt Benckiser bows out of race for Merck's c...	01-May-2014	Telegraph
Patents Ending, Eli Lilly Chases New Drugs	01-Oct-2010	New York Times
Another Loss for Pfizer in Drug Suits	25-Nov-2009	New York Times
Bristol-Myers, partner AstraZeneca get EU approv...	06-Oct-2009	Chicago Tribune

Patent Woes Threaten Drug Firms	07-Mar-2011	New York Times
Stocks cut losses on Fed's economic stimulus plans	11-Aug-2010	LA Times
Sanofi and Merck Announce $4 Billion Merial Sale	31-Jul-2009	Intl Herald Tribune
Stocks end back-and-forth day slightly higher	22-Jul-2009	Wall Street Journal
Stocks climb on better-than-expected earnings	22-Jul-2009	LA Times

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.